We aimed to identify pathogenic CSF1R<sup>high</sup> MPS subsets, characterize their ligand-receptor circuits, and define the CSF1R-PPARα axis in disease pathogenesis. This evidence concerns the gene CSF1R and mucopolysaccharidosis.